American Heart Journal
Volume 154, Issue 2 , Pages 277.e1-277.e8 , August 2007

Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: A report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

  • Barry H. Greenberg, MD

      Affiliations

    • University of California-San Diego Medical Center, San Diego, CA
    • Corresponding Author InformationReprint requests: Barry H. Greenberg, MD, University of California-San Diego Medical Center, 200 W. Arbor Drive, #8411, San Diego, CA 92103-8411.
    • ,
  • William T. Abraham, MD

      Affiliations

    • Ohio State University, Columbus, OH
    • ,
  • Nancy M. Albert, PhD, RN

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Karen Chiswell, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Robert Clare, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Northwestern Feinberg School of Medicine, Chicago, IL
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Duke University Medical Center, Durham, NC
    • ,
  • Jie Lena Sun, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Baylor University Medical Center, Dallas, TX
    • ,
  • James B. Young, MD

      Affiliations

    • Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Gregg C. Fonarow, MD

      Affiliations

    • UCLA Medical Center, Los Angeles, CA

Received 30 January 2007 ,Accepted 1 May 2007.

  • Image Result

    Percent of patients receiving HF measures at hospital discharge by diabetes status.

    Percent of patients receiving HF measures at hospital discharge by diabetes status.

  • Image Result

    Eligible patients receiving other medications at hospital discharge by diabetes status.ACEI/ARB use in patients with LVSD, excluding patients with contraindications. †β-Blocker use in patients with LV

    Eligible patients receiving other medications at hospital discharge by diabetes status.ACEI/ARB use in patients with LVSD, excluding patients with contraindications. †β-Blocker use in patients with LVSD, excluding patients with contraindications. ‡Statin use in patients with medical history of coronary artery disease, cerebrovascular accident/transient ischemic attack, diabetes, hyperlipidemia, or peripheral vascular disease. §Aldosterone antagonist use in patients with LVSD. ||Warfarin use in patients with chronic or paroxysmal atrial fibrillation.

 The OPTIMIZE-HF registry and this study were supported by GlaxoSmithKline, Philadelphia, PA.

 The OPTIMIZE-HF registry is registered: www.clinicaltrials.gov, study number NCT00344513.

PII: S0002-8703(07)00414-0

doi: 10.1016/j.ahj.2007.05.001

American Heart Journal
Volume 154, Issue 2 , Pages 277.e1-277.e8 , August 2007

Article Tools

* Image Usage & Resolution